斯特里克尼精液与大脑科伊兹 (Atractylodes Macrocephala Koidz) 结合,通过调节亡来减轻类风湿性关节炎的作用
Xiaoxin Wang1, Yuling Li1, Huihui Lou1
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Ji'nan, 250355, Shandong, Peoples R China.
Current computer-aided drug design
|August 8, 2023
概括
斯特里克尼精液与Atractylodes Macrocephala Koidz (SA) 结合,显示出抗风湿性关节炎 (RA) 的作用. 它在辅助性关节炎 (AA) 鼠中的治疗机制涉及调节亡信号通路,为RA提供潜在的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 传统中国医药 传统中国医药
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,导致关节疼痛和残疾.
- 斯特里奇尼精液与Atractylodes Macrocephala Koidz (SA) 结合显示了对RA的治疗作用,没有毒性.
- 对于SA治疗RA的精确药理机制尚不清楚.
研究的目的:
- 阐明SA在治疗RA中的药理机制.
- 确定与RA相关的SA的活性成分,目标和途径.
- 通过体内实验验验证网络药理学预测.
主要方法:
- 网络药理学被用来选SA的活性成分,预测标,并确定途径.
- 进行了基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 分析.
- 建立了一个辅助性关节炎 (AA) 鼠标模型,用于预测机制的体内验证.
主要成果:
- 网络药理学确定了81个活性成分和141个SA的目标,其中ALB,IL-6,TNF和IL-1β是RA的核心目标.
- GO和KEGG分析表明SA与TNF信号通路在RA治疗中的关联.
- 在体内实验证实了SA在改善AA老鼠症状,调节免疫反应和调节亡相关蛋白质 (例如Fas,Bax,Caspase 3,Bcl-2) 的有效性.
结论:
- 酸盐表现出显著的抗RA效应.
- 在AA大鼠中SA的治疗机制与亡信号通路的调节有关.
- SA提出了一种对RA治疗有前途的治疗策略.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


